Article
Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression.
Cell death & disease - 20 Sept 2021
Zhang Meng, Sun Yin, Huang Chi-Ping, Luo Jie, Zhang Li, Meng Jialin, Liang Chaozhao, Chang Chawnshang
Abstract excerpt
Long non-coding RNAs (lncRNAs) have been found to play critical roles in regulating gene expression, but their function in translational control is poorly understood. We found lnc-OPHN1-5, which lies close to the androgen receptor (AR) gene on chromosome X, increased prostate cancer (PCa) Enzalutamide (Enz) sensitivity via decreasing AR protein expression and associated activity. Mechanism dissection revealed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
